Abstract:Abstract Background Cystic fibrosis is the most common autosomal recessive genetic disease in Caucasians. It is caused by mutations in the CFTR gene, leading to poor hydration of mucus and impairment of the respiratory, digestive, and reproductive organ functions. Advancements in medical care have led to markedly increased longevity of patients with cystic fibrosis, but new complications have emerged, such as early onset of colorectal cancer. Although the pathogenesis of colorectal cancer in cystic fibrosis remains unclear, altered host-microbe interactions might play a critical role. To investigate this, we characterized changes in the microbiome and host gene expression in the colonic mucosa of cystic fibrosis patients relative to healthy controls, and identified host gene-microbiome interactions in the colon of cystic fibrosis patients. Methods We performed RNA-seq on colonic mucosa samples from cystic fibrosis patients and healthy controls to determine differentially expressed host genes. We also performed 16S rRNA sequencing to characterize the colonic mucosal microbiome and identify gut microbes that are differentially abundant between patients and healthy controls. Lastly, we modeled associations between relative abundances of specific bacterial taxa in the gut mucosa and host gene expression. Results We find that 1543 genes, including CFTR , show differential expression in the colon of cystic fibrosis patients compared to healthy controls. These genes are enriched with functions related to gastrointestinal and colorectal cancer, such as metastasis of colorectal cancer, tumor suppression, p53, and mTOR signaling pathways. In addition, patients with cystic fibrosis show decreased gut microbial diversity, decreased abundance of butyrate producing bacteria, such as Ruminococcaceae and Butyricimonas , and increased abundance of other taxa, such as Actinobacteria and Clostridium . An integrative analysis identified colorectal cancer-related genes, including LCN2 and DUOX2 , for which gene expression is correlated with the abundance of colorectal cancer-associated bacteria, such as Ruminococcaceae and Veillonella . Conclusions In addition to characterizing host gene expression and mucosal microbiome in cystic fibrosis patients, our study explored the potential role of host-microbe interactions in the etiology of colorectal cancer in cystic fibrosis. Our results provide biomarkers that may potentially serve as targets for stratifying risk of colorectal cancer in patients with cystic fibrosis.

Airway Mucosal Host Defense is Key to Genomic Regulation of Cystic Fibrosis Lung Disease Severity

Gene Expression in Transformed Lymphocytes Reveals Variation in Endomembrane and Hla Pathways Modifying Cystic Fibrosis Pulmonary Phenotypes

Genetic Modifiers of Cystic Fibrosis Lung Disease Severity

Genome-wide Association Meta-Analysis Identifies Five Modifier Loci of Lung Disease Severity in Cystic Fibrosis

Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci

Cystic Fibrosis Gene Modifierslc26a9modulates Airway Response to CFTR-directed Therapeutics

Genetic variation in severe cystic fibrosis liver disease is associated with novel mechanisms for disease pathogenesis

Interactions between the gut microbiome and host gene regulation in cystic fibrosis

Genetic Evidence Supports the Development of SLC26A9 Targeting Therapies for the Treatment of Lung Disease

Multiple Apical Plasma Membrane Constituents Are Associated with Susceptibility to Meconium Ileus in Individuals with Cystic Fibrosis

Widespread alterations in systemic immune profile are linked to lung function heterogeneity and airway microbes in cystic fibrosis

Inflammatory Activity of Epithelial Stem Cell Variants from Cystic Fibrosis Lungs Is Not Resolved by CFTR Modulators

Aberrant immune programming in neutrophils in cystic fibrosis

Single-cell RNA-Sequencing Co-Expression Analysis with CFTR in Lung Tissue

Role of airway surface liquid and submucosal glands in cystic fibrosis lung disease.

Mechanisms by which the cystic fibrosis transmembrane conductance regulator may influence SARS-CoV-2 infection and COVID-19 disease severity

Genome-Wide Association Study of Susceptibility Topseudomonas Aeruginosainfection in Cystic Fibrosis

Airway inflammation accelerates pulmonary exacerbations in cystic fibrosis

Genetic Regulation of Gene Expression in the Lung Identifiescst3andcd22as Potential Causal Genes for Airflow Obstruction

IL-1β Dominates the Promucin Secretory Cytokine Profile in Cystic Fibrosis

Genome-wide Association Study of Susceptibility to Pseudomonas Aeruginosa Infection in Cystic Fibrosis.